Brief: Ajanta Pharma's Paithan facility been issued one procedural related 483 by USFDA
Feb 9 (Reuters) - Ajanta Pharma Ltd AJPH.NS
* Says company's Paithan facility was recently inspected by
US FDA and company has issued one procedural related 483.
* Says company has issued one procedural related 483
* Says is in process of responding to same within stipulated
time prescribed by US FDA.
Source text - (http://bit.ly/2lt7NpZ)
Further company coverage: AJPH.NS
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on Ajanta Pharma
See all newsIndia's Ajanta Pharma falls as analysts say growth to moderate in H2
Brief: Ajanta Pharma Limited Sept-Quarter Consol Net Profit 3.88 Billion Rupees
India's Ajanta Pharma jumps on June quarter profit jump
Brief: Ajanta Pharma June-Quarter Consol PAT 3.34 Billion Rupees
Brief: Ajanta Pharma Receives US FDA Establishment Inspection Report For Paithan Facility